A 0 1 0 1 O
non 2 5 2 5 O
- 5 6 5 6 O
nodal 6 11 6 11 O
lesion 12 18 12 18 O
is 19 21 19 21 O
considered 22 32 22 32 O
measurable 33 43 33 43 O
if 44 46 44 46 O
its 47 50 47 50 O
longest 51 58 51 58 O
diameter 59 67 59 67 O
can 68 71 68 71 O
be 72 74 72 74 O
accurately 75 85 75 85 O
measured 86 94 86 94 O
as 95 97 95 97 O
> 98 99 98 99 O
= 99 100 99 100 O
2.0 101 104 101 104 B-lower_bound
cm 105 107 105 107 I-lower_bound
with 108 112 108 112 O
chest 113 118 113 118 B-treatment
x 119 120 119 120 I-treatment
- 120 121 120 121 I-treatment
ray 121 124 121 124 I-treatment
, 124 125 124 125 O
or 126 128 126 128 O
as 129 131 129 131 O
> 132 133 132 133 O
= 133 134 133 134 O
1.0 135 138 135 138 B-lower_bound
cm 139 141 139 141 I-lower_bound
with 142 146 142 146 O
computed 147 155 147 155 B-treatment
tomography 156 166 156 166 I-treatment
( 167 168 167 168 I-treatment
CT 168 170 168 170 I-treatment
) 170 171 170 171 I-treatment
scan 172 176 172 176 I-treatment
, 176 177 176 177 O
CT 178 180 178 180 O
component 181 190 181 190 O
of 191 193 191 193 O
a 194 195 194 195 O
positron 196 204 196 204 B-treatment
emission 205 213 205 213 I-treatment
tomography 214 224 214 224 I-treatment
( 225 226 225 226 I-treatment
PET)/CT 226 233 226 233 I-treatment
, 233 234 233 234 O
or 235 237 235 237 O
magnetic 238 246 238 246 B-treatment
resonance 247 256 247 256 I-treatment
imaging 257 264 257 264 I-treatment
( 265 266 265 266 I-treatment
MRI 266 269 266 269 I-treatment
) 269 270 269 270 I-treatment

Absolute 0 8 271 279 B-clinical_variable
neutrophil 9 19 280 290 I-clinical_variable
count 20 25 291 296 I-clinical_variable
( 26 27 297 298 I-clinical_variable
ANC 27 30 298 301 I-clinical_variable
) 30 31 301 302 I-clinical_variable
> 32 33 303 304 O
= 33 34 304 305 O
1500 35 39 306 310 B-lower_bound
/ 39 40 310 311 I-lower_bound
mm^3 40 44 311 315 I-lower_bound

Age 0 3 316 319 B-age
< 4 5 320 321 O
60 6 8 322 324 B-upper_bound
and 9 12 325 328 O
amenorrhea 13 23 329 339 B-clinical_variable
> 24 25 340 341 O
12 26 28 342 344 B-lower_bound
consecutive 29 40 345 356 O
months 41 47 357 363 O
without 48 55 364 371 O
another 56 63 372 379 O
cause 64 69 380 385 O
and 70 73 386 389 O
documented 74 84 390 400 O
follicle 85 93 401 409 B-clinical_variable
stimulating 94 105 410 421 I-clinical_variable
hormone 106 113 422 429 I-clinical_variable
( 114 115 430 431 I-clinical_variable
FSH 115 118 431 434 I-clinical_variable
) 118 119 434 435 I-clinical_variable
level 120 125 436 441 I-clinical_variable
of 126 128 442 444 O
> 129 130 445 446 O
35 131 133 447 449 B-lower_bound
mIU 134 137 450 453 I-lower_bound
/ 137 138 453 454 I-lower_bound
mL 138 140 454 456 I-lower_bound

Age 0 3 457 460 B-age
> 4 5 461 462 O
= 5 6 462 463 O
60 7 9 464 466 B-lower_bound
and 10 13 467 470 O
amenorrhea 14 24 471 481 B-clinical_variable
> 25 26 482 483 O
12 27 29 484 486 B-lower_bound
consecutive 30 41 487 498 O
months 42 48 499 505 O

Alanine 0 7 506 513 B-clinical_variable
transaminase 8 20 514 526 I-clinical_variable
( 21 22 527 528 I-clinical_variable
ALT 22 25 528 531 I-clinical_variable
) 25 26 531 532 I-clinical_variable
= 27 28 533 534 O
< 28 29 534 535 O
3 30 31 536 537 B-upper_bound
x 32 33 538 539 I-upper_bound
ULN 34 37 540 543 I-upper_bound
(= 38 40 544 546 O
< 40 41 546 547 O
5 42 43 548 549 B-upper_bound
x 44 45 550 551 I-upper_bound
ULN 46 49 552 555 I-upper_bound
for 50 53 556 559 O
patients 54 62 560 568 O
with 63 67 569 573 O
liver 68 73 574 579 O
involvement 74 85 580 591 O
) 85 86 591 592 O

Calculated 0 10 593 603 B-clinical_variable
creatinine 11 21 604 614 I-clinical_variable
clearance 22 31 615 624 I-clinical_variable
must 32 36 625 629 O
be 37 39 630 632 O
> 40 41 633 634 O
= 41 42 634 635 O
45 43 45 636 638 B-lower_bound
ml 46 48 639 641 I-lower_bound
/ 48 49 641 642 I-lower_bound
min 49 52 642 645 I-lower_bound
using 53 58 646 651 O
the 59 62 652 655 O
Cockcroft 63 72 656 665 O
- 72 73 665 666 O
Gault 73 78 666 671 O
formula 79 86 672 679 O

Chemotherapy 0 12 680 692 B-treatment
= 13 14 693 694 O
< 14 15 694 695 O
21 16 18 696 698 B-upper_bound
days 19 23 699 703 I-upper_bound

Eastern 0 7 704 711 B-clinical_variable
Cooperative 8 19 712 723 I-clinical_variable
Oncology 20 28 724 732 I-clinical_variable
Group 29 34 733 738 I-clinical_variable
( 35 36 739 740 I-clinical_variable
ECOG 36 40 740 744 I-clinical_variable
) 40 41 744 745 I-clinical_variable
performance 42 53 746 757 I-clinical_variable
status 54 60 758 764 I-clinical_variable
: 60 61 764 765 O
0 62 63 766 767 B-lower_bound
, 63 64 767 768 O
1 65 66 769 770 O
, 66 67 770 771 O
2 68 69 772 773 B-upper_bound

HER2 0 4 774 778 B-clinical_variable
IHC 5 8 779 782 I-clinical_variable
expression 9 19 783 793 I-clinical_variable
of 20 22 794 796 O
0 23 24 797 798 O
, 24 25 798 799 O
1 26 27 800 801 O
+ 27 28 801 802 O
and 29 32 803 806 O
ISH 33 36 807 810 O
not 37 40 811 814 O
done 41 45 815 819 O

HER2 0 4 820 824 B-clinical_variable
immunohistochemistry 5 25 825 845 I-clinical_variable
( 26 27 846 847 I-clinical_variable
IHC 27 30 847 850 I-clinical_variable
) 30 31 850 851 I-clinical_variable
expression 32 42 852 862 O
of 43 45 863 865 O
0 46 47 866 867 B-lower_bound
, 47 48 867 868 O
1 49 50 869 870 B-upper_bound
+ 50 51 870 871 O
and 52 55 872 875 O
in 56 58 876 878 B-clinical_variable
- 58 59 878 879 I-clinical_variable
situ 59 63 879 883 I-clinical_variable
hybridization 64 77 884 897 I-clinical_variable
( 78 79 898 899 I-clinical_variable
ISH 79 82 899 902 I-clinical_variable
) 82 83 902 903 I-clinical_variable
non 84 87 904 907 O
- 87 88 907 908 O
amplified 88 97 908 917 O

Hemoglobin 0 10 918 928 B-clinical_variable
> 11 12 929 930 O
= 12 13 930 931 O
9.0 14 17 932 935 B-lower_bound
g 18 19 936 937 I-lower_bound
/ 19 20 937 938 I-lower_bound
dL 20 22 938 940 I-lower_bound

Histologic 0 10 941 951 O
proof 11 16 952 957 O
of 17 19 958 960 O
metastatic 20 30 961 971 O
or 31 33 972 974 O
locally 34 41 975 982 O
advanced 42 50 983 991 O
, 50 51 991 992 O
unresectable 52 64 993 1005 O
breast 65 71 1006 1012 B-cancer
cancer 72 78 1013 1019 I-cancer

History 0 7 1020 1027 O
of 8 10 1028 1030 O
primary 11 18 1031 1038 O
, 18 19 1038 1039 O
operable 20 28 1040 1048 O
ER+/HER2âˆ’ 29 38 1049 1058 O
invasive 39 47 1059 1067 B-cancer
breast 48 54 1068 1074 I-cancer
cancer 55 61 1075 1081 I-cancer

Hormonal 0 8 1082 1090 B-clinical_variable
therapy 9 16 1091 1098 I-clinical_variable
= 17 18 1099 1100 O
< 18 19 1100 1101 O
14 20 22 1102 1104 B-upper_bound
days 23 27 1105 1109 I-upper_bound

IHC 0 3 1110 1113 B-treatment
not 4 7 1114 1117 O
done 8 12 1118 1122 O
and 13 16 1123 1126 O
ISH 17 20 1127 1130 B-chronic_disease
non 21 24 1131 1134 O
- 24 25 1134 1135 O
amplified 25 34 1135 1144 O

Immunotherapy 0 13 1145 1158 B-treatment
= 14 15 1159 1160 O
< 15 16 1160 1161 O
21 17 19 1162 1164 B-upper_bound
days 20 24 1165 1169 I-upper_bound

Monoclonal 0 10 1170 1180 B-clinical_variable
antibodies 11 21 1181 1191 I-clinical_variable
= 22 23 1192 1193 O
< 23 24 1193 1194 O
14 25 27 1195 1197 B-upper_bound
days 28 32 1198 1202 I-upper_bound

No 0 2 1203 1205 O
prior 3 8 1206 1211 B-treatment
treatment 9 18 1212 1221 I-treatment
with 19 23 1222 1226 O
an 24 26 1227 1229 O
aurora 27 33 1230 1236 B-treatment
Kinase 34 40 1237 1243 I-treatment
inhibitor 41 50 1244 1253 I-treatment
( 51 52 1254 1255 O
either 52 58 1255 1261 O
an 59 61 1262 1264 O
aurora 62 68 1265 1271 B-treatment
A 69 70 1272 1273 I-treatment
or 71 73 1274 1276 O
pan 74 77 1277 1280 B-treatment
- 77 78 1280 1281 I-treatment
aurora 78 84 1281 1287 I-treatment
kinase 85 91 1288 1294 I-treatment
inhibitor 92 101 1295 1304 I-treatment
) 101 102 1304 1305 O

Not 0 3 1306 1309 O
receiving 4 13 1310 1319 O
administration 14 28 1320 1334 O
of 29 31 1335 1337 O
proton 32 38 1338 1344 B-treatment
pump 39 43 1345 1349 I-treatment
inhibitor 44 53 1350 1359 I-treatment
, 53 54 1359 1360 O
H2 55 57 1361 1363 B-treatment
antagonist 58 68 1364 1374 I-treatment
, 68 69 1374 1375 O
or 70 72 1376 1378 O
pancreatic 73 83 1379 1389 B-treatment
enzymes 84 91 1390 1397 I-treatment

Patients 0 8 1398 1406 O
who 9 12 1407 1410 O
receive 13 20 1411 1418 O
stereotactic 21 33 1419 1431 B-treatment
radiosurgery 34 46 1432 1444 I-treatment
or 47 49 1445 1447 O
whole 50 55 1448 1453 B-treatment
brain 56 61 1454 1459 I-treatment
radiation 62 71 1460 1469 I-treatment
for 72 75 1470 1473 O
brain 76 81 1474 1479 B-cancer
metastases 82 92 1480 1490 I-cancer
are 93 96 1491 1494 O
eligible 97 105 1495 1503 O
only 106 110 1504 1508 O
if 111 113 1509 1511 O
they 114 118 1512 1516 O
are 119 122 1517 1520 O
asymptomatic 123 135 1521 1533 O
and 136 139 1534 1537 O
have 140 144 1538 1542 O
stable 145 151 1543 1549 O
MRI 152 155 1550 1553 B-treatment
scans 156 161 1554 1559 O
for 162 165 1560 1563 O
3 166 167 1564 1565 O
consecutive 168 179 1566 1577 O
months 180 186 1578 1584 O
, 186 187 1584 1585 O
including 188 197 1586 1595 O
< 198 199 1596 1597 O
28 200 202 1598 1600 B-upper_bound
days 203 207 1601 1605 I-upper_bound
prior 208 213 1606 1611 I-upper_bound
to 214 216 1612 1614 O
pre 217 220 1615 1618 O
- 220 221 1618 1619 O
registration 221 233 1619 1631 O

Platelet 0 8 1632 1640 B-clinical_variable
count 9 14 1641 1646 I-clinical_variable
> 15 16 1647 1648 O
= 16 17 1648 1649 O
100,000 18 25 1650 1657 B-lower_bound
/ 25 26 1657 1658 I-lower_bound
mm^3 26 30 1658 1662 I-lower_bound

Previous 0 8 1663 1671 O
bilateral 9 18 1672 1681 O
oophorectomy 19 31 1682 1694 B-treatment

Prior 0 5 1695 1700 B-treatment
treatment 6 15 1701 1710 I-treatment
with 16 20 1711 1715 I-treatment
fulvestrant 21 32 1716 1727 I-treatment
in 33 35 1728 1730 I-treatment
the 36 39 1731 1734 I-treatment
metastatic 40 50 1735 1745 I-treatment
setting 51 58 1746 1753 I-treatment
is 59 61 1754 1756 O
required 62 70 1757 1765 O
, 70 71 1765 1766 O
except 72 78 1767 1773 O
for 79 82 1774 1777 O
patients 83 91 1778 1786 O
with 92 96 1787 1791 O
a 97 98 1792 1793 O
history 99 106 1794 1801 O
of 107 109 1802 1804 O
ER 110 112 1805 1807 O
- 112 113 1807 1808 O
negative 113 121 1808 1816 O
metastatic 122 132 1817 1827 B-cancer
breast 133 139 1828 1834 I-cancer
cancer 140 146 1835 1841 I-cancer

Radiation 0 9 1842 1851 B-clinical_variable
therapy 10 17 1852 1859 I-clinical_variable
= 18 19 1860 1861 O
< 19 20 1861 1862 O
14 21 23 1863 1865 B-upper_bound
days 24 28 1866 1870 I-upper_bound

Receipt 0 7 1871 1878 O
of 8 10 1879 1881 O
corticosteroids 11 26 1882 1897 B-clinical_variable
= 27 28 1898 1899 O
< 28 29 1899 1900 O
7 30 31 1901 1902 B-upper_bound
days 32 36 1903 1907 I-upper_bound
prior 37 42 1908 1913 I-upper_bound
to 43 45 1914 1916 O
registration 46 58 1917 1929 O
, 58 59 1929 1930 O
unless 60 66 1931 1937 O
patient 67 74 1938 1945 O
has 75 78 1946 1949 O
been 79 83 1950 1954 O
taking 84 90 1955 1961 O
a 91 92 1962 1963 O
continuous 93 103 1964 1974 O
dose 104 108 1975 1979 O
of 109 111 1980 1982 O
no 112 114 1983 1985 O
more 115 119 1986 1990 O
than 120 124 1991 1995 O
15 125 127 1996 1998 B-lower_bound
mg 128 130 1999 2001 I-lower_bound
/ 130 131 2001 2002 I-lower_bound
day 131 134 2002 2005 I-lower_bound
of 135 137 2006 2008 O
prednisone 138 148 2009 2019 B-treatment
for 149 152 2020 2023 O
at 153 155 2024 2026 O
least 156 161 2027 2032 O
30 162 164 2033 2035 B-lower_bound
days 165 169 2036 2040 I-lower_bound
prior 170 175 2041 2046 I-lower_bound
to 176 178 2047 2049 O
registration 179 191 2050 2062 O

Systemic 0 8 2063 2071 B-treatment
infection 9 18 2072 2081 I-treatment
requiring 19 28 2082 2091 I-treatment
intravenous 29 40 2092 2103 I-treatment
( 41 42 2104 2105 I-treatment
IV 42 44 2105 2107 I-treatment
) 44 45 2107 2108 I-treatment
antibiotic 46 56 2109 2119 I-treatment
therapy 57 64 2120 2127 I-treatment
= 65 66 2128 2129 O
< 66 67 2129 2130 O
14 68 70 2131 2133 B-upper_bound
days 71 75 2134 2138 I-upper_bound
prior 76 81 2139 2144 I-upper_bound
to 82 84 2145 2147 O
registration 85 97 2148 2160 O

Total 0 5 2161 2166 B-clinical_variable
bilirubin 6 15 2167 2176 I-clinical_variable
= 16 17 2177 2178 O
< 17 18 2178 2179 O
1.5 19 22 2180 2183 B-upper_bound
x 23 24 2184 2185 I-upper_bound
upper 25 30 2186 2191 I-upper_bound
limit 31 36 2192 2197 I-upper_bound
of 37 39 2198 2200 I-upper_bound
normal 40 46 2201 2207 I-upper_bound
( 47 48 2208 2209 I-upper_bound
ULN 48 51 2209 2212 I-upper_bound
) 51 52 2212 2213 I-upper_bound

Treatment 0 9 2214 2223 B-treatment
with 10 14 2224 2228 O
clinically 15 25 2229 2239 O
significant 26 37 2240 2251 O
enzyme 38 44 2252 2258 B-treatment
inducers 45 53 2259 2267 I-treatment
, 53 54 2267 2268 O
such 55 59 2269 2273 O
as 60 62 2274 2276 O
the 63 66 2277 2280 O
enzyme 67 73 2281 2287 O
- 73 74 2287 2288 O
inducing 74 82 2288 2296 O
antiepileptic 83 96 2297 2310 B-treatment
drugs 97 102 2311 2316 I-treatment
phenytoin 103 112 2317 2326 B-treatment
, 112 113 2326 2327 O
carbamazepine 114 127 2328 2341 B-treatment
or 128 130 2342 2344 O
phenobarbital 131 144 2345 2358 B-treatment
, 144 145 2358 2359 O
or 146 148 2360 2362 O
rifampin 149 157 2363 2371 B-treatment
, 157 158 2371 2372 O
rifabutin 159 168 2373 2382 B-treatment
, 168 169 2382 2383 O
rifapentine 170 181 2384 2395 B-treatment
or 182 184 2396 2398 O
St. 185 188 2399 2402 B-treatment
John 189 193 2403 2407 I-treatment
's 193 195 2407 2409 I-treatment
wort 196 200 2410 2414 I-treatment
= 201 202 2415 2416 O
< 202 203 2416 2417 O
14 204 206 2418 2420 B-upper_bound
days 207 211 2421 2425 I-upper_bound
prior 212 217 2426 2431 I-upper_bound
to 218 220 2432 2434 O
registration 221 233 2435 2447 O

Unlimited 0 9 2448 2457 O
prior 10 15 2458 2463 B-treatment
endocrine 16 25 2464 2473 I-treatment
therapy 26 33 2474 2481 I-treatment
regimens 34 42 2482 2490 O
in 43 45 2491 2493 O
the 46 49 2494 2497 O
metastatic 50 60 2498 2508 B-cancer
setting 61 68 2509 2516 O
are 69 72 2517 2520 O
allowed 73 80 2521 2528 O

